Evidence mapPaperPMID 40544228Full record

ReviewMolecular biology reports2025

Exosomes applications in kidney diseases.

Dan Li, Pei Feng, Yaru Wang, Junzheng Yang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dan LiNursing School, North Henan Medical University, Xinxiang, 453003, China.
Pei FengNursing School, North Henan Medical University, Xinxiang, 453003, China.
Yaru WangNursing School, North Henan Medical University, Xinxiang, 453003, China.
Junzheng YangGuangdong nephrotic drug Engineering Technology Research Center, Institute of Consun Co. for Chinese Medicine in Kidney Diseases, Guangzhou, 510530, China. yangjunzheng606403@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney diseases are prevalent worldwide and represent a significant cause of mortality, posing a substantial threat to public health. Exosomes are a type of nanoscale lipid-encapsulated structure with a diameter of 30-200 nm. They contain a variety of substances including proteins, mRNA, and microRNA. It has been demonstrated that they fulfill a significant function in the regulation of intercellular communication. The inherent characteristics of exosomes, including their ability to regulate complex intracellular pathways, suggest a significant therapeutic potential in the treatment of numerous diseases, including renal diseases. The present review aims to provide a comprehensive overview of the application of exosome in kidney diseases, exploring the underlying mechanisms that underpin their function. Furthermore, it examines the limitations of current applications and potential solutions to address these challenges. It is hoped that this review will contribute to the advancement of exosome research and application in the field of kidney diseases.

Indexed as

ExosomesKidney DiseasesAnimalsCell CommunicationHumansMicroRNAsMicroRNAsAKIApplicationCKDExosomesIgANKidney diseaseMechanism

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.